
zzso is a valuable zzso therapy for patients with zzso multiple zzso Many zzso zzso reactions to zzso zzso beta are described at injection zzso zzso after subcutaneous injection of beta zzso is a rare adverse event; we describe two such cases at beta zzso injection zzso 

Two women aged 22 years and 45 years with severe multiple sclerosis receiving zzso with beta zzso were admitted to an emergency department following the appearance of extremely painful zzso at injection sites rendering walking impossible after several months of zzso zzso One of the patients had zzso zzso tests showed zzso and zzso zzso in one-woman and zzso zzso in the zzso zzso scanners showed extensive avascular necrosis of soft tissue without zzso in both zzso zzso withdrawal and surgical zzso was carried out in one case and beta zzso was successfully reintroduced in both zzso 

Only two cases have been reported of zzso induced by subcutaneous beta zzso zzso zzso such cases may mimic infectious zzso The present cases show that zzso may be useful in diagnosis and that the vascular toxicity of zzso beta probably plays a role in zzso Temporary withdrawal of treatment, rotation of several injection sites and alternative routes of administration may all be zzso 

